Related Experiment Video
Updated: Jul 25, 2025

Author Spotlight: Genetic Profiling for Fluorouracil Response in Gastric Cancer
Published on: May 10, 2024
MPL gene mutation is a possible risk factor for thrombosis in patients with essential thrombocythemia in Japan
Chiho Furuya1, Yoshinori Hashimoto2,3, Soji Morishita3,4
1Department of Hematology, Juntendo University Graduate School of Medicine, Tokyo, Japan.
Objectives:
Since MPL mutation is a rare driver gene mutation found in a small number of essential thrombocythemia (ET) patients, the clinical characteristics of patients with MPL mutations and their association with thrombotic events have not yet been elucidated in Japan.
Methods:
We enrolled 579 Japanese ET patients based on the diagnostic criteria of the WHO classification 2017 and compared clinical characteristics of MPL-mutated patients (n = 22; 3.8%) to JAK2V617F-mutated (n = 299; 51.6%), CALR-mutated (n = 144; 24.9%), and triple-negative (TN) (n = 114; 19.7%) patients.
Results:
Thrombosis during follow up was observed in 4 out of 22 (18.2%) in the MPL-mutated group, which was the highest among all driver gene mutation groups (JAK2V617F-mutated, 8.7%; CALR-mutated, 3.5%; TN,1.8%). The MPL- and JAK2V617F-mutated groups had worse thrombosis-free survival (TFS) than the CALR-mutated (p = 0.043) and TN groups (p = 0.006). Univariable analysis revealed that a history of thrombosis was a possible risk factor for thrombosis among MPL-mutated patients (hazard ratio: 9.572, p = 0.032).
Conclusions:
MPL-mutated ET patients should require more intensive management to prevent recurrence of thrombosis.
Insights
MPL mutations in essential thrombocythemia (ET) patients are linked to the highest thrombosis risk. These patients require intensive management to prevent recurrent thrombotic events.
Area of Science:
- Hematology
- Oncology
- Genetics
Background:
- MPL mutations are rare driver gene mutations in essential thrombocythemia (ET).
- Clinical characteristics and thrombosis association in Japanese ET patients with MPL mutations remain unclear.
Purpose of the Study:
- To elucidate the clinical characteristics of Japanese ET patients with MPL mutations.
- To investigate the association between MPL mutations and thrombotic events in ET.
Main Methods:
- Enrolled 579 Japanese ET patients based on WHO 2017 classification.
- Compared clinical characteristics of MPL-mutated patients (n=22) with JAK2V617F (n=299), CALR (n=144), and triple-negative (n=114) groups.
Main Results:
- MPL-mutated ET patients showed the highest thrombosis rate (18.2%) during follow-up.
- MPL- and JAK2V617F-mutated groups had significantly worse thrombosis-free survival (TFS) compared to CALR-mutated and triple-negative groups.
- A history of thrombosis was a significant risk factor for recurrent thrombosis in MPL-mutated ET patients.
Conclusions:
- MPL-mutated ET patients exhibit a high risk of thrombosis.
- Intensive management strategies are crucial for MPL-mutated ET patients to prevent thrombosis recurrence.
More Related Videos
07:00A Method to Study the C924T Polymorphism of the Thromboxane A2 Receptor Gene
Published on: April 1, 2019
05:58Digital Polymerase Chain Reaction Assay for the Genetic Variation in a Sporadic Familial Adenomatous Polyposis Patient Using the Chip-in-a-tube Format
Published on: August 20, 2018
Related Concept Videos
Translation
Translation Produces the Building Blocks of Life
Proteins are...
Cancer Prevention
Some...
Cancer-Critical Genes II: Tumor Suppressor Genes
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
Mismatch Repair
The Mutator Protein Family Plays a Key Role in DNA Mismatch Repair
The human genome has more than 3 billion base pairs of DNA per cell. Prior to cell division, that vast amount of genetic...
Cancer-Critical Genes I: Proto-oncogenes
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...